Tag:
Oncolytics
Latest Headlines
Latest Headlines
Oncolytics Biotech surges on lung cancer data
the Calgary-based biotech reported tumor shrinkage in 95% of patients analyzed who took its experimental anticancer virus and a pair of chemotherapy drugs for a form of lung cancer.
UPDATED: Oncolytics soars on early peek at Phase III study of cancer therapy
Shares of Oncolytics Biotech jumped more than 60% this morning after the Canadian biotech revealed positive data on one endpoint from a Phase III study of its anticancer virus in patients with head and neck cancers.
Oncolytics raises $24M for cancer trial
Canada's Oncolytics, which is developing oncolytic viruses as potential cancer therapeutics, has raised about $24 million through the sale of 5.44 million units of the company's stock for $4.60 each.
